344 related articles for article (PubMed ID: 22290687)
1. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.
Huang HC; Wang SS; Hsin IF; Chang CC; Lee FY; Lin HC; Chuang CL; Lee JY; Hsieh HG; Lee SD
Hepatology; 2012 Jul; 56(1):248-58. PubMed ID: 22290687
[TBL] [Abstract][Full Text] [Related]
2. The beneficial effects of curcumin in cirrhotic rats with portal hypertension.
Hsu SJ; Lee JY; Lin TY; Hsieh YH; Huang HC; Lee FY; Lin HC; Hou MC; Lee SD
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29162665
[TBL] [Abstract][Full Text] [Related]
3. Green tea polyphenol decreases the severity of portosystemic collaterals and mesenteric angiogenesis in rats with liver cirrhosis.
Hsu SJ; Wang SS; Hsin IF; Lee FY; Huang HC; Huo TI; Lee WS; Lin HC; Lee SD
Clin Sci (Lond); 2014 May; 126(9):633-44. PubMed ID: 24063570
[TBL] [Abstract][Full Text] [Related]
4. Endothelin receptor blockers reduce shunting and angiogenesis in cirrhotic rats.
Hsu SJ; Lin TY; Wang SS; Chuang CL; Lee FY; Huang HC; Hsin IF; Lee JY; Lin HC; Lee SD
Eur J Clin Invest; 2016 Jun; 46(6):572-80. PubMed ID: 27091078
[TBL] [Abstract][Full Text] [Related]
5. Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats.
Hsu SJ; Lee FY; Wang SS; Hsin IF; Lin TY; Huang HC; Chang CC; Chuang CL; Ho HL; Lin HC; Lee SD
Hepatology; 2015 May; 61(5):1672-84. PubMed ID: 25557829
[TBL] [Abstract][Full Text] [Related]
6. The Beneficial Effects of P2X7 Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis.
Tung HC; Lee FY; Wang SS; Tsai MH; Lee JY; Huo TI; Huang HC; Chuang CL; Lin HC; Lee SD
PLoS One; 2015; 10(5):e0124654. PubMed ID: 25933224
[TBL] [Abstract][Full Text] [Related]
7. The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension.
Lin HC; Yang YY; Tsai TH; Huang CM; Huang YT; Lee FY; Liu TT; Lee SD
J Hepatol; 2011 Jun; 54(6):1145-53. PubMed ID: 21145843
[TBL] [Abstract][Full Text] [Related]
8. Insulin reverses major portal hypertension-related derangements in rats with liver cirrhosis and diabetes.
Hsin IF; Huang HC; Chang CC; Hsu SJ; Lee FY; Huo TI; Chuang CL; Hou MC; Lee SD
Clin Sci (Lond); 2018 Nov; 132(22):2391-2405. PubMed ID: 30348829
[TBL] [Abstract][Full Text] [Related]
9. Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats.
Huang HC; Tsai MH; Chang CC; Pun CK; Huang YH; Hou MC; Lee FY; Hsu SJ
Clin Sci (Lond); 2021 Dec; 135(24):2709-2728. PubMed ID: 34870313
[TBL] [Abstract][Full Text] [Related]
10. Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats.
Pun CK; Huang HC; Chang CC; Chuang CL; Yen CH; Hsu SJ; Lee FY; Hou MC; Huang YH
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299285
[TBL] [Abstract][Full Text] [Related]
11. NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats.
Angermayr B; Fernandez M; Mejias M; Gracia-Sancho J; Garcia-Pagan JC; Bosch J
Gut; 2007 Apr; 56(4):560-4. PubMed ID: 16854998
[TBL] [Abstract][Full Text] [Related]
12. Folic acid ameliorates homocysteine-induced angiogenesis and portosystemic collaterals in cirrhotic rats.
Ho HL; Tsai MH; Hsieh YH; Huo TI; Chang CC; Lee FY; Huang HC; Hou MC; Lee SD
Ann Hepatol; 2019; 18(4):633-639. PubMed ID: 31078441
[TBL] [Abstract][Full Text] [Related]
13. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
[TBL] [Abstract][Full Text] [Related]
14. 2'-Hydroxyflavanone ameliorates mesenteric angiogenesis and portal-systemic collaterals in rats with liver fibrosis.
Hsin IF; Lee JY; Huo TI; Lee FY; Huang HC; Hsu SJ; Wang SS; Ho HL; Lin HC; Lee SD
J Gastroenterol Hepatol; 2016 May; 31(5):1045-51. PubMed ID: 26474184
[TBL] [Abstract][Full Text] [Related]
15. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study.
Geerts AM; De Vriese AS; Vanheule E; Van Vlierberghe H; Mortier S; Cheung KJ; Demetter P; Lameire N; De Vos M; Colle I
Liver Int; 2006 Sep; 26(7):889-98. PubMed ID: 16911473
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.
Schwabl P; Payer BA; Grahovac J; Klein S; Horvatits T; Mitterhauser M; Stift J; Boucher Y; Trebicka J; Trauner M; Angermayr B; Fuhrmann V; Reiberger T; Peck-Radosavljevic M
J Hepatol; 2014 Jun; 60(6):1135-42. PubMed ID: 24530596
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic Rats.
Hsu SJ; Wang SS; Huo TI; Lee FY; Huang HC; Chang CC; Hsin IF; Ho HL; Lin HC; Lee SD
J Pharmacol Exp Ther; 2015 Oct; 355(1):117-24. PubMed ID: 26260462
[TBL] [Abstract][Full Text] [Related]
18. Cediranib ameliorates portal hypertensive syndrome via inhibition of VEGFR-2 signaling in cirrhotic rats.
Fan Q; Wu G; Chen M; Luo G; Wu Z; Huo H; Li H; Zheng L; Luo M
Eur J Pharmacol; 2024 Feb; 964():176278. PubMed ID: 38158116
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine deteriorates intrahepatic derangement and portal-systemic collaterals in cirrhotic rats.
Tung HC; Hsu SJ; Tsai MH; Lin TY; Hsin IF; Huo TI; Lee FY; Huang HC; Ho HL; Lin HC; Lee SD
Clin Sci (Lond); 2017 Jan; 131(1):69-86. PubMed ID: 27803296
[TBL] [Abstract][Full Text] [Related]
20. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.
Moezi L; Gaskari SA; Liu H; Baik SK; Dehpour AR; Lee SS
Br J Pharmacol; 2006 Dec; 149(7):898-908. PubMed ID: 17043671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
